Reinventing the antimicrobial pipeline in response to the global crisis of antimicrobial-resistant infections

The pipeline for new antibiotics is dry. Despite the creation of public/private initiatives like Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator (Carb-X) and the Antimicrobial Resistance (AMR) Centre, the current focus on ‘push-pull’ incentives for the pharmaceutical industry s...

Descripción completa

Detalles Bibliográficos
Autores principales: Singer, Andrew C., Kirchhelle, Claas, Roberts, Adam P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2019
Materias:
Opinion Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6426076/
https://www.ncbi.nlm.nih.gov/pubmed/30906539
http://dx.doi.org/10.12688/f1000research.18302.1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6426076/
https://www.ncbi.nlm.nih.gov/pubmed/30906539
http://dx.doi.org/10.12688/f1000research.18302.1

Ejemplares similares